US Health Policy Update: Important Provisions of the Build Back Better Act
The recent Build Back Better Act presents an opportunity to completely change the healthcare market landscape in the US if certain provisions make it through the Senate. In this article, experts Nathan Swilling and Nikhil Pinto discuss four key provisions to watch as the Act goes through the Senate.
While evolution of the US health policy landscape generally follows a glacial pace, the recent passage of the Build Back Better Act (BBBA) by the United States House of Representatives (the House) offers renewed momentum for several potential upheavals to the healthcare landscape if certain BBBA provisions make it through the Senate. The BBBA includes several key prescription drug provisions, versions of which have been discussed for many years and have fallen short of approval. However, increasing bipartisan agreement and media focus on these topics, as well as the impending 2022 mid-term elections make for an interesting road ahead.
